Literature DB >> 26722297

Twist-related protein 1-mediated regulation of mesenchymal change contributes to the migration and invasion of cervical cancer cells.

Danqing Wang1, Qingli Li1, Kemin Li1, Ping Xiao1, Rutie Yin1.   

Abstract

Twist-related protein 1 (Twist1), is a class II basic helix-loop-helix transcription factor, which has been demonstrated to be a major regulator of epithelial-mesenchymal transition (EMT), and therefore is involved in promoting carcinoma metastasis. Previous studies have demonstrated that Twist1 expression is upregulated in cervical cancer cases with poor clinical outcomes. However, the mechanisms that mediate the role of Twist1 in cervical cancer metastasis are poorly understood. To the best of our knowledge, the present study provides the first evidence that the downregulation of Twist1 by short hairpin RNA lentivirus (LV-shRNA) resulted in the inhibition of invasion and migration of cervical cancer cells. Furthermore, the present study presents evidence that reducing Twist1 expression prevents cervical cancer cells from undergoing EMT. The expression of the epithelial cell marker, E-cadherin, was elevated; and the expression levels of mesenchymal cell markers [fibronectin, vimentin, matrix metalloproteinase-9 (MMP-9) and MMP-2] were reduced in the LV-sh-Twist1 group in cervical cells. Collectively, these findings indicate that Twist1-mediated modulation of EMT is important in the invasion and migration of cervical cells, and also indicates the potential therapeutic importance of strategies involving the inactivation of Twist1-mediated mesenchymal changes in cervical cancer.

Entities:  

Keywords:  Twist-related protein 1; cervical cancer; epithelial-mesenchymal transition; invasion; migration

Year:  2015        PMID: 26722297      PMCID: PMC4665933          DOI: 10.3892/ol.2015.3650

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

Review 1.  Radiotherapy and chemoradiation after surgery for early cervical cancer.

Authors:  Linda Rogers; Shing Shun N Siu; David Luesley; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 3.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

4.  Bone metastasis in cervical cancer patients over a 10-year period.

Authors:  Duangmani Thanapprapasr; Adisak Nartthanarung; Puchong Likittanasombut; Nathpong Israngura Na Ayudhya; Chuenkamon Charakorn; Umaporn Udomsubpayakul; Thanya Subhadarbandhu; Sarikapan Wilailak
Journal:  Int J Gynecol Cancer       Date:  2010-04       Impact factor: 3.437

Review 5.  Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms.

Authors:  Qian Qin; Young Xu; Tao He; Chunlin Qin; Jianming Xu
Journal:  Cell Res       Date:  2011-08-30       Impact factor: 25.617

Review 6.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

7.  Effect and mechanism of the Twist gene on invasion and metastasis of gastric carcinoma cells.

Authors:  Geng-Qiu Luo; Jing-He Li; Ji-Fang Wen; Yan-Hong Zhou; Yong-Bin Hu; Jian-Hua Zhou
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

Review 8.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

9.  Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Joana Liu Donaher; Sridhar Ramaswamy; Raphael A Itzykson; Christophe Come; Pierre Savagner; Inna Gitelman; Andrea Richardson; Robert A Weinberg
Journal:  Cell       Date:  2004-06-25       Impact factor: 41.582

Review 10.  Epithelial-mesenchymal plasticity in carcinoma metastasis.

Authors:  Jeff H Tsai; Jing Yang
Journal:  Genes Dev       Date:  2013-10-15       Impact factor: 11.361

View more
  4 in total

1.  Silencing of BAG3 inhibits the epithelial-mesenchymal transition in human cervical cancer.

Authors:  Fei Song; Geng Wang; Zhifang Ma; Yuebing Ma; Yingying Wang
Journal:  Oncotarget       Date:  2017-09-08

2.  Endothelin-1 promotes epithelial-mesenchymal transition in human chondrosarcoma cells by repressing miR-300.

Authors:  Min-Huan Wu; Pei-Han Huang; Mingli Hsieh; Chun-Hao Tsai; Hsien-Te Chen; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2016-10-25

3.  miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1.

Authors:  Yuan-Yuan Fang; Ming-Rong Tan; Jian Zhou; Li Liang; Xiao-Yun Liu; Kun Zhao; Er-Chen Bao
Journal:  Onco Targets Ther       Date:  2019-11-18       Impact factor: 4.147

Review 4.  Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?

Authors:  Giovanni Barillari; Roberto Bei; Vittorio Manzari; Andrea Modesti
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.